Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Toth

Showing results (81-90 of 425) with videos related to

Pageof 43
Sort By:
Expert Opinion on Pharmacotherapy|February 16, 2005
Simvastatin plus ezetimibe: combination therapy for the management of dyslipidaemiaPeter P Toth, Michael H Davidson
JACC. Advances|June 28, 2024
Coronary Atherosclerosis: Causes, Consequences, and the Passage of TimePeter P Toth, Allan D Sniderman
Current Drug Targets. Cardiovascular & Haematological Disorders|March 1, 2006
Cholesterol absorption blockade with ezetimibePeter P Toth, Michael H Davidson
The American Journal of Cardiology|December 6, 2007
High-density lipoprotein metabolism: potential therapeutic targetsMichael H Davidson, Peter P Toth
The Journal of Family Practice|August 9, 2008
High-dose statin therapy: benefits and safety in aggressive lipid loweringPeter P Toth, Michael H Davidson
Progress in Cardiovascular Diseases|December 9, 2004
Comparative effects of lipid-lowering therapiesMichael H Davidson, Peter P Toth
Current Opinion in Cardiology|June 26, 2004
Therapeutic interventions targeted at the augmentation of reverse cholesterol transportPeter P Toth, Michael H Davidson
Obesity (Silver Spring, Md.)|January 25, 2019
Trends in Lipids, Obesity, Metabolic Syndrome, and Diabetes Mellitus in the United States: An NHANES Analysis (2003-2004 to 2013-2014)Michael K Palmer, Peter P Toth
European Cardiology|March 18, 2020
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular DiseaseAlberto J Lorenzatti, Peter P Toth
Journal of Clinical Lipidology|February 5, 2011
Implications of recent statin trials for primary care practicePeter P Toth, Chris J Cadman
Pageof 43

Showing results (81-90 of 425) with videos related to

Sort By:
Pageof 43
Expert Opinion on Pharmacotherapy|February 16, 2005
Simvastatin plus ezetimibe: combination therapy for the management of dyslipidaemiaPeter P Toth, Michael H Davidson
JACC. Advances|June 28, 2024
Coronary Atherosclerosis: Causes, Consequences, and the Passage of TimePeter P Toth, Allan D Sniderman
Current Drug Targets. Cardiovascular & Haematological Disorders|March 1, 2006
Cholesterol absorption blockade with ezetimibePeter P Toth, Michael H Davidson
The American Journal of Cardiology|December 6, 2007
High-density lipoprotein metabolism: potential therapeutic targetsMichael H Davidson, Peter P Toth
The Journal of Family Practice|August 9, 2008
High-dose statin therapy: benefits and safety in aggressive lipid loweringPeter P Toth, Michael H Davidson
Progress in Cardiovascular Diseases|December 9, 2004
Comparative effects of lipid-lowering therapiesMichael H Davidson, Peter P Toth
Current Opinion in Cardiology|June 26, 2004
Therapeutic interventions targeted at the augmentation of reverse cholesterol transportPeter P Toth, Michael H Davidson
Obesity (Silver Spring, Md.)|January 25, 2019
Trends in Lipids, Obesity, Metabolic Syndrome, and Diabetes Mellitus in the United States: An NHANES Analysis (2003-2004 to 2013-2014)Michael K Palmer, Peter P Toth
European Cardiology|March 18, 2020
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular DiseaseAlberto J Lorenzatti, Peter P Toth
Journal of Clinical Lipidology|February 5, 2011
Implications of recent statin trials for primary care practicePeter P Toth, Chris J Cadman
Pageof 43